ENDRA Life Sciences NDRA
NASDAQ NDRA
$4.78 +0.10 (+2.14%)
As of: Oct 22, 2026 · 3:57 PM EDT

ENDRA Life Sciences (NDRA) Other Accumulated Expenses (2020 - 2021)

Updated

ENDRA Life Sciences (NDRA) recorded Other Accumulated Expenses of $1.45 million in Q3 2021.

Analysis

ENDRA Life Sciences (NDRA) Other Accumulated Expenses (2020 - 2021) Analysis & Trends

At the end of FY2020, ENDRA Life Sciences reported Other Accumulated Expenses of $910,183.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.71 Bn 229.74 Bn 4.88 Bn
2 Abbott Laboratories 178.38 Bn 148.81 Bn 7.27 Bn
3 Danaher 161.61 Bn 145.42 Bn 3.61 Bn
4 Intuitive Surgical 154.15 Bn 134.44 Bn 2.08 Bn
5 Medtronic 123.21 Bn 88.46 Bn 6.34 Bn
6 Stryker 117.50 Bn 103.61 Bn 4.50 Bn
7 Boston Scientific 67.50 Bn 62.26 Bn 3.85 Bn
8 Becton Dickinson 54.80 Bn 51.95 Bn 2.32 Bn
9 Edwards Lifesciences 51.78 Bn 35.79 Bn 1.35 Bn
10 ENDRA Life Sciences 6.33 Mn 2.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 1.45 Mn
Mar 31, 2021 1.51 Mn
Dec 31, 2020 910,183.00
API Access

ENDRA Life Sciences Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=NDRA&period=max&api_key=YOUR_API_KEY